PCI Biotech: Mandatory notification of trade

The Chairman Hans Peter Bøhn has today, 14 December 2016, subscribed for 33.556
new shares in PCI Biotech Holding ASA (the "Company") at a subscription price of
NOK 7 per share by exercising 33.556 subscription rights in the Company's
ongoing rights issue. After the transaction, Hans Peter Bøhn will have a total
shareholding in the company of 83.556 shares and 0 subscription rights in the
rights issue. Hans Peter Bøhn has previously entered into a guarantee agreement
of NOK 1 000 000 in relation to the rights issue, and todays exercise of
subscription rights will, in compliance with the guarantee agreement, reduce the
guarantee liability correspondingly.

Contact information:
PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo
Ronny Skuggedal, CFO, rs@pcibiotech.no, Mobile: +47 9400 5757

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.